Form 4: Cryoport Director Robert J. Hariri Sells 12,500 Shares of Common Stock

Cryoport Director Robert J. Hariri reported the sale of 12,500 shares of Cryoport common stock at $6.10 per share on May 28, 2025, reducing his direct beneficial ownership to 8,061 shares.

Summary

• Robert J. Hariri, a Director of Cryoport, Inc. (CYRX), reported a transaction involving the company's common stock.
• On May 28, 2025, Mr. Hariri disposed of 12,500 shares of common stock.
• The shares were sold at a price of $6.10 per share.
• Following this transaction, Mr. Hariri's direct beneficial ownership in Cryoport, Inc. stands at 8,061 shares.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 4

Explanation: The sale of a significant number of shares by a director, even if pre-planned under a 10b5-1 plan, can be perceived negatively as it reduces insider ownership and may suggest a lack of confidence or a desire for diversification.

Positives

• The transaction was conducted under a Rule 10b5-1(c) plan, indicating a pre-scheduled sale rather than a reaction to immediate, undisclosed company news.

Negatives

• A director of the company sold a significant number of shares (12,500), which can be perceived by the market as a reduction in insider confidence or a desire for diversification.
• The sale reduced the director's direct beneficial ownership in the company to 8,061 shares.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This SEC Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders may interpret the insider sale as a negative signal, potentially impacting investor confidence in the company's near-term prospects.

Key Dates

Keywords

Cryoport, CYRX, Form 4, insider trading, stock sale, director, beneficial ownership, Robert J. Hariri, 10b5-1 plan